Does EPCORITAMAB Cause Bronchopulmonary aspergillosis? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Bronchopulmonary aspergillosis have been filed in association with EPCORITAMAB (EPKINLY). This represents 0.9% of all adverse event reports for EPCORITAMAB.
18
Reports of Bronchopulmonary aspergillosis with EPCORITAMAB
0.9%
of all EPCORITAMAB reports
14
Deaths
18
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From EPCORITAMAB?
Of the 18 reports, 14 (77.8%) resulted in death, 18 (100.0%) required hospitalization, and 8 (44.4%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
Yes, Bronchopulmonary aspergillosis is listed as a known adverse reaction in the official FDA drug label for EPCORITAMAB.
What Other Side Effects Does EPCORITAMAB Cause?
Cytokine release syndrome (551)
Pyrexia (258)
Off label use (229)
Febrile neutropenia (219)
Pneumonia (154)
Covid-19 (125)
Sepsis (106)
Hypotension (95)
Diffuse large b-cell lymphoma (86)
Neutropenia (84)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which EPCORITAMAB Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
EPCORITAMAB vs EPCORITAMAB-BYSP
EPCORITAMAB vs EPERISONE
EPCORITAMAB vs EPHEDRINE
EPCORITAMAB vs EPINASTINE
EPCORITAMAB vs EPINEPHRINE